Medicare Enrolled

Dr. Satish Shanbhag, MD,MPH

Internal Medicine · Fleming Island, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Consulting-driven
2370 MARKET DR, Fleming Island, FL 32003
9042646201
In practice since 2007 (18 years)
NPI: 1215140454 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Shanbhag from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Shanbhag? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Shanbhag

Dr. Satish Shanbhag is an internal medicine in Fleming Island, FL, with 18 years in practice. Based on federal Medicare data, Dr. Shanbhag performed 40,780 Medicare services across 1,159 unique beneficiaries.

Between the years covered by Open Payments, Dr. Shanbhag received a total of $15,799 from 44 pharmaceutical and/or device companies across 130 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Shanbhag is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice▲ Top 1% volume in FL$ $15,799 industry payments

Medicare Practice Summary

Medicare Utilization ↗
40,780
Medicare services
Top 1% in FL for internal medicine
1,159
Unique beneficiaries
$6
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~2,266 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Iron infusion (Injectafer)20,250$1$4
Epoetin alfa injection (Retacrit) for anemia4,940$6$27
Anti-nausea injection (fosaprepitant)4,800$0$5
Denosumab injection (Prolia/Xgeva)3,240$18$41
Dexamethasone injection (steroid)1,682$0$1
Anti-nausea injection (Aloxi/palonosetron)890$1$75
Blood draw (venipuncture)860$8$18
Injection, granisetron hydrochloride, 100 mcg810$0$41
Complete blood count (CBC) with differential789$8$41
Office visit, established patient (30-39 min)569$95$162
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less423$21$90
Administration of chemotherapy into vein, 1 hour or less312$97$355
Drug injection, under skin or into muscle240$11$42
Office visit, established patient (20-29 min)186$64$104
Administration of chemotherapy into vein, each additional hour149$22$80
Injection of additional new drug or substance into vein110$11$55
Injection, diphenhydramine hcl, up to 50 mg101$1$4
Administration of additional new drug or substance into vein, 1 hour or less77$44$175
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less66$48$160
Infusion into a vein for hydration, each additional hour56$9$40
Enhancing oncology model (eom) monthly enhanced oncology services (meos) payment for eom enhanced services56$73$70
Hospital follow-up visit, moderate complexity44$62$115
Infusion, normal saline solution , 1000 cc43$2$97
New patient office visit (45-59 min)34$129$265
Infusion into a vein for hydration, 31-60 minutes30$25$130
Initial hospital admission, moderate complexity23$103$225
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
51.2% high complexity
42.4% medium
6.5% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$15,799
Total received (2018-2024)
Avg $2,257/year across 7 years
Top 4% in FL for internal medicine
44
Companies
130
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$12,783 (80.9%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,511 (9.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,505 (9.5%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,676
2023
$290
2022
$198
2021
$1,208
2020
$6,773
2019
$4,378
2018
$275

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Takeda Pharmaceuticals U.S.A., Inc.
$6,059
AstraZeneca Pharmaceuticals LP
$2,130
BeiGene USA, Inc.
$1,970
Celgene Corporation
$1,523
GENZYME CORPORATION
$1,084
Alnylam Pharmaceuticals Inc.
$482
BeiGene, Ltd.
$450
SANOFI-AVENTIS U.S. LLC
$350
Janssen Biotech, Inc.
$283
Novartis Pharmaceuticals Corporation
$237
GlaxoSmithKline, LLC.
$212
Eisai Inc.
$105
Janssen Scientific Affairs, LLC
$69
Incyte Corporation
$68
G1 Therapeutics, Inc.
$66
PFIZER INC.
$59
Alexion Pharmaceuticals, Inc.
$56
Genentech USA, Inc.
$46
Exelixis Inc.
$40
Foundation Medicine, Inc.
$38
Daiichi Sankyo Inc.
$36
Octapharma USA, Inc.
$32
Taiho Oncology, Inc.
$29
EISAI INC.
$29
Ipsen Biopharmaceuticals, Inc
$29
JAZZ PHARMACEUTICALS INC.
$28
Agios Pharmaceuticals, Inc.
$27
Astellas Pharma US Inc
$25
Gilead Sciences, Inc.
$25
AVEO Pharmaceuticals, Inc.
$23
Bayer HealthCare Pharmaceuticals Inc.
$21
Merck Sharp & Dohme LLC
$20
Rigel Pharmaceuticals, Inc.
$17
Immunocore Limited
$16
Lilly USA, LLC
$15
Sun Pharmaceutical Industries Inc.
$14
SOBI, INC
$14
Aurobindo Pharma USA, Inc.
$13
Adaptive Biotechnologies Corporation
$13
Global Blood Therapeutics, Inc.
$12
EUSA Pharma (US) LLC
$12
Merck Sharp & Dohme Corporation
$10
Sirtex Medical Inc
$9
Secura Bio, Inc.
$4
Top 3 companies account for 64.3% of total payments
Associated products mentioned in payments ›
Aliqopa · BLENREP · BRUKINSA · CABLIVI · CALQUENCE · COSELA · Cabometyx · DARZALEX · ELITEK · ERLEADA · Enhertu · FOTIVDA · FOUNDATIONONE · Fabhalta · Farydak · GAZYVA · IBRANCE · IMBRUVICA · IMFINZI · INQOVI · JAKAFI · JEVTANA · KEYTRUDA · KIMMTRAK · KISQALI · LIBTAYO · Lenvima · Lunsumio · MEKINIST · MONJUVI · NINLARO · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OXBRYTA · Onivyde · PADCEV · PLUVICTO · PROMACTA · PYRUKYND · Phesgo · Pomalyst · RYBREVANT · Rezlidhia · SCEMBLIX · SIR-Spheres Microspheres · Stivarga · Sylvant · TABRECTA · TECVAYLI · Truqap · ULTOMIRIS · VELCADE · VERZENIO · VONJO · VYNDAQEL · Xtandi · YONSA · ZEJULA · ZEPZELCA · Zevalin · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (81%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 4% for internal medicine in FL.

Equivalent to $39 per 100 Medicare services performed
Looking for a internal medicine in Fleming Island?
Compare internal medicines in the Fleming Island area by procedure volume, costs, and industry payment transparency.
Browse internal medicines nearby

Geographic Context

Internal Medicines within 10 mi
920
Per 100K population
411.8
County median income
$86,094
Nearest hospital
HCA FLORIDA ORANGE PARK HOSPITAL
5.3 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Shanbhag is a mixed practice specialist, with above-average Medicare volume (top 1% in FL), and high industry engagement (consulting-driven, top 4%), with 18 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Shanbhag experienced with iron infusion (injectafer)?
Based on Medicare claims data, Dr. Shanbhag performed 20,250 iron infusion (injectafer) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Shanbhag receive payments from pharmaceutical companies?
Yes. Dr. Shanbhag received a total of $15,799 from 44 companies across 130 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Shanbhag's costs compare to other internal medicines in Fleming Island?
Dr. Shanbhag's average Medicare payment per service is $6. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Shanbhag) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →